# Forest Service to Close 57 Research Stations, Including 6 in California – SFGATE > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/forest-service-research-stations-closure-california-impact/ > **Published:** 2026-04-08T20:30:57-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T17:21:08-04:00 > **Clinical Summary:** Explore the forest service research stations closure and its impact on environmental research infrastructure, including 6 stations in California. --- ✦ New CED Clinical Relevance  #70Notable Clinical Interest  Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News  |  CED Clinic Research InfrastructurePolicyEnvironmental Why This Matters This appears to be a general forestry/research infrastructure story without direct relevance to [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) or patient care. The closure of Forest Service research stations, while potentially impacting environmental research broadly, does not present immediate clinical implications for cannabis therapeutics or patient management. Clinical Summary The Forest Service is closing 57 research stations including 6 in California as part of organizational restructuring. Without specific details about cannabis-related research programs at these facilities, there is no clear connection to [clinical cannabis](https://cedclinic.com/entourage-effect-cannabis-clinical-breeding-benefits/) medicine. Forest Service research typically focuses on forestry, ecology, and land management rather than [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/) cultivation or therapeutic research. Dr. Caplan’s Take “This doesn’t appear to have direct clinical relevance to [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/). Unless these stations were conducting specific research on therapeutic cannabis cultivation or environmental factors affecting [medical cannabis](https://cedclinic.com/therapeutic-benefits-of-thc/), this is outside our clinical purview.” Clinical Perspective 🧠 Clinicians should focus on peer-reviewed [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) from medical institutions and [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/) rather than forestry service developments. Any potential impacts on [cannabis research](https://cedclinic.com/pediatric-cannabis-certification-care-children/) infrastructure would need to be specifically documented to be clinically relevant. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20Forest%20Service%20to%20close%2057%20research%20stations%2C%20including%206%20in%20California%20-%20SFGATE%20%40drcaplan&url=https%3A//www.sfgate.com/bayarea/article/forest-service-research-stations-22192356.php)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//www.sfgate.com/bayarea/article/forest-service-research-stations-22192356.php)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20Forest%20Service%20to%20close%2057%20research%20stations%2C%20including%206%20in%20California%20-%20SFGATE%20--%20via%20%40drcaplan.bsky.social%20https%3A//www.sfgate.com/bayarea/article/forest-service-research-stations-22192356.php)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://www.sfgate.com/bayarea/article/forest-service-research-stations-22192356.php](https://www.sfgate.com/bayarea/article/forest-service-research-stations-22192356.php) Table of Contents - [FAQ](#FAQ)[What is the clinical relevance rating of this cannabis research?](#What_is_the_clinical_relevance_rating_of_this_cannabis_research) - [What type of cannabis news does this article cover?](#What_type_of_cannabis_news_does_this_article_cover) - [Why is this article marked as “New”?](#Why_is_this_article_marked_as_8220New8221) - [What does “Notable Clinical Interest” mean for healthcare providers?](#What_does_8220Notable_Clinical_Interest8221_mean_for_healthcare_providers) - [How does this relate to current cannabis research infrastructure?](#How_does_this_relate_to_current_cannabis_research_infrastructure) - [Related](#Related) ## FAQ #### What is the clinical relevance rating of this cannabis research? This article has been assigned CED Clinical Relevance #70, indicating “Notable Clinical Interest.” This rating suggests the findings represent emerging developments or policy changes that healthcare professionals should monitor closely. #### What type of cannabis news does this article cover? This article focuses on research infrastructure, policy, and environmental aspects of cannabis. It appears to address foundational elements that support cannabis research and regulation rather than specific clinical outcomes. #### Why is this article marked as “New”? The “New” designation indicates this is recently published or updated information from CED Clinic. This ensures readers are aware they’re viewing the latest available data on this cannabis-related topic. #### What does “Notable Clinical Interest” mean for healthcare providers? This classification means the content contains emerging findings or policy developments worth monitoring. Healthcare providers should be aware of these developments as they may impact future clinical practice or patient care decisions. #### How does this relate to current cannabis research infrastructure? The article addresses research infrastructure components that support cannabis studies and policy development. This includes environmental considerations and regulatory frameworks that enable scientific investigation of cannabis for medical purposes. [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence Feds to close Grand Rapids lab that does global-leading research on forestry, climate change Learn about the federal decision to close a leading forestry and climate change research lab and its broader implications. Read More Carney unveils early infrastructure spending plan | Watch – MSN Discover the latest infrastructure spending plans that could influence research and environmental projects. Watch Now This state agency was created to investigate Texas universities. How that works is a mystery. Explore the creation and function of a state agency investigating universities, highlighting governance and oversight. Learn More ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).